{{Rsnum
|rsid=10170310
|Gene=SPOPL
|Chromosome=2
|position=138521352
|Orientation=plus
|GMAF=0.2433
|Gene_s=SPOPL
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 68.1 | 30.1 | 1.8
| HCB | 61.8 | 33.1 | 5.1
| JPT | 48.2 | 42.9 | 8.9
| YRI | 32.9 | 49.3 | 17.8
| ASW | 51.8 | 37.5 | 10.7
| CHB | 61.8 | 33.1 | 5.1
| CHD | 64.8 | 27.8 | 7.4
| GIH | 54.0 | 40.0 | 6.0
| LWK | 35.2 | 44.8 | 20.0
| MEX | 67.2 | 31.0 | 1.7
| MKK | 47.3 | 39.3 | 13.3
| TSI | 72.0 | 25.0 | 3.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23241943
  |Trait=Response to antipsychotic treatment
  |Title=Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.
  |RiskAllele=G
  |Pval=1E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{ population diversity
| geno1 = (A;A)
| geno2 = (A;G)
| geno3 = (G;G)
| CEU | 66.7 | 33.3 | 0.0
| HCB | 60.0 | 35.6 | 4.4
| JPT | 44.4 | 42.2 | 13.3
| YRI | 26.7 | 55.0 | 18.3
| ASW | 50.0 | 37.5 | 12.5
| CHD | 65.9 | 28.2 | 5.9
| GIH | 56.3 | 37.9 | 5.7
| LWK | 0 | 0 | 0
| MEX | 70.0 | 30.0 | 0.0
| MKK | 47.1 | 39.1 | 13.8
| TSI | 73.3 | 24.4 | 2.3
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}